Hong-Xia Qiu

Design and Synthesis of Orally Bioavailable 4-Methyl Heteroaryldihydropyrimidine Based Hepatitis B Virus (HBV) Capsid Inhibitors

Zongxing Qiu, Xianfeng Lin, Mingwei Zhou et al. · Journal of Medicinal Chemistry · 2016 · 75 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Discovery of Fluoromethylketone-Based Peptidomimetics as Covalent ATG4B (Autophagin-1) Inhibitors

Zongxing Qiu, Bernd Kuhn, Johannes D. Aebi et al. · ACS Medicinal Chemistry Letters · 2016 · 67 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Discovery and Pre-Clinical Characterization of Third-Generation 4-H Heteroaryldihydropyrimidine (HAP) Analogues as Hepatitis B Virus (HBV) Capsid Inhibitors

Zongxing Qiu, Xianfeng Lin, Weixing Zhang et al. · Journal of Medicinal Chemistry · 2017 · 59 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Prognostic significance of ATM and TP53 deletions in Chinese patients with chronic lymphocytic leukemia

Wei Xu, Jianyong Li, Yujie Wu et al. · Leukemia Research · 2007 · 52 citations

Medicine, Molecular Genetics, Oncology +14

Acetaminophen-induced hepatotoxicity of gel entrapped rat hepatocytes in hollow fibers

Chong Shen, Guoliang Zhang, Hong-Xia Qiu et al. · Chemico-Biological Interactions · 2006 · 47 citations

Pharmacy, Pharmacology, Toxicology +16